• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯霉素及琥珀酸氯霉素在婴幼儿和儿童中的药代动力学

Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children.

作者信息

Kauffman R E, Miceli J N, Strebel L, Buckley J A, Done A K, Dajani A S

出版信息

J Pediatr. 1981 Feb;98(2):315-20. doi: 10.1016/s0022-3476(81)80670-1.

DOI:10.1016/s0022-3476(81)80670-1
PMID:7463235
Abstract

The metabolism and elimination of chloramphenicol-3-monosuccinate was studied in 45 infants and children, ages 3 days to 16 years, during intravenous administration. The apparent half-life of chloramphenicol was extremely variable, ranging from 1.7 to 12.0 hours with a mean of 5.1 hours. Apparent half-lives were inversely correlated with age. Chloramphenicol-S serum concentration declined biexponentially in most patients, with an estimated mean initial half-life of 0.7 hours and a subsequent longer mean half-life of 2.2 hours. Chloramphenicol-S persisted in serum up to six hours after a dose, and comprised a significantly larger fraction of total chloramphenicol in the serum of infants under one month of age than in older infants and children. A widely variable fraction of the administered chloramphenicol-S dose, with a mean of 33%, was excreted in the urine unchanged and was, therefore, not bioavailable in active form. Mean renal clearance of chloramphenicol-S was 259.5 ml/minute/1.73 M2, four times the mean creatinine clearance, indicating active tubular secretion. Variable hydrolysis and renal elimination of nonhydrolyzed chloramphenicol-S reduces the bioavailability of the antibiotic and appears to contribute substantially to the wide variation in apparent half-life and poor correlation between dose and serum concentration of free chloramphenicol.

摘要

在45名年龄从3天至16岁的婴幼儿及儿童静脉注射期间,研究了琥珀氯霉素-3-单酯的代谢及消除情况。氯霉素的表观半衰期变化极大,范围为1.7至12.0小时,平均为5.1小时。表观半衰期与年龄呈负相关。在大多数患者中,氯霉素-S血清浓度呈双指数下降,估计平均初始半衰期为0.7小时,随后较长的平均半衰期为2.2小时。给药后,氯霉素-S在血清中持续存在长达6小时,且在1个月龄以下婴儿血清中占总氯霉素的比例显著高于较大婴儿及儿童。给药的氯霉素-S剂量中,有很大一部分(平均为33%)以原形经尿液排出,因此无活性形式的生物利用度。氯霉素-S的平均肾清除率为259.5 ml/分钟/1.73 M2,是平均肌酐清除率的4倍,表明存在肾小管主动分泌。非水解的氯霉素-S的可变水解及肾消除降低了抗生素的生物利用度,似乎是导致表观半衰期广泛变化以及游离氯霉素剂量与血清浓度之间相关性差的主要原因。

相似文献

1
Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children.氯霉素及琥珀酸氯霉素在婴幼儿和儿童中的药代动力学
J Pediatr. 1981 Feb;98(2):315-20. doi: 10.1016/s0022-3476(81)80670-1.
2
Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate.
Clin Pharmacol Ther. 1981 Sep;30(3):368-72. doi: 10.1038/clpt.1981.174.
3
Chloramphenicol dosage and pharmacokinetics in infants and children.
J Clin Pharmacol. 1983 Feb-Mar;23(2-3):106-12. doi: 10.1002/j.1552-4604.1983.tb02712.x.
4
Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients.
Dev Pharmacol Ther. 1983;6(1):23-32. doi: 10.1159/000457274.
5
Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.
J Pediatr. 1981 Dec;99(6):963-7. doi: 10.1016/s0022-3476(81)80034-0.
6
Chloramphenicol pharmacokinetics in infants and young children.
Pediatrics. 1980 Oct;66(4):579-84.
7
Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.氯霉素及琥珀氯霉素的临床药代动力学
Clin Pharmacokinet. 1984 May-Jun;9(3):222-38. doi: 10.2165/00003088-198409030-00004.
8
Chloramphenicol succinate kinetics in infants and young children.
Pediatr Pharmacol (New York). 1982;2(2):93-103.
9
Use of chloramphenicol palmitate in neonates.
J Pediatr. 1984 Jul;105(1):113-6. doi: 10.1016/s0022-3476(84)80374-1.
10
Chloramphenicol disposition in infants and children.
J Pediatr. 1979 Dec;95(6):1071-7. doi: 10.1016/s0022-3476(79)80315-7.

引用本文的文献

1
Esterases in serum-containing growth media counteract chloramphenicol acetyltransferase activity in vitro.含血清生长培养基中的酯酶在体外可抵消氯霉素乙酰转移酶的活性。
Antimicrob Agents Chemother. 1999 Mar;43(3):655-60. doi: 10.1128/AAC.43.3.655.
2
Pharmacokinetics of anti-infective agents in paediatric patients.抗感染药物在儿科患者中的药代动力学。
Clin Pharmacokinet. 1994 May;26(5):374-95. doi: 10.2165/00003088-199426050-00005.
3
Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function.
静脉注射琥珀氯霉素钠在肾功能和肝功能正常的成年患者中的药代动力学。
J Pharmacokinet Biopharm. 1982 Dec;10(6):601-14. doi: 10.1007/BF01062543.
4
Why still prescribe chloramphenicol in 1983? Comparison of the clinical and biological hematologic effects of chloramphenicol and thiamphenicol.
Blut. 1983 Dec;47(6):317-20. doi: 10.1007/BF00320345.
5
Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status.不同营养状况的埃塞俄比亚儿童体内氯霉素的药代动力学
Eur J Clin Pharmacol. 1983;24(6):819-23. doi: 10.1007/BF00607094.
6
Chloramphenicol in the 1980s.20世纪80年代的氯霉素。
Drugs. 1984 Oct;28(4):281-91. doi: 10.2165/00003495-198428040-00001.
7
Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.氯霉素及琥珀氯霉素的临床药代动力学
Clin Pharmacokinet. 1984 May-Jun;9(3):222-38. doi: 10.2165/00003088-198409030-00004.
8
Comparison of ceftriaxone and traditional therapy of bacterial meningitis.头孢曲松与细菌性脑膜炎传统疗法的比较。
Antimicrob Agents Chemother. 1984 Jan;25(1):40-4. doi: 10.1128/AAC.25.1.40.
9
Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.头孢噻肟在患脑膜炎儿童脑脊液中的扩散。
Antimicrob Agents Chemother. 1985 Jul;28(1):138-40. doi: 10.1128/AAC.28.1.138.
10
Interaction between chloramphenicol and acetaminophen.氯霉素与对乙酰氨基酚之间的相互作用。
Arch Dis Child. 1986 Nov;61(11):1121-4. doi: 10.1136/adc.61.11.1121.